Home » TEVA PHARMACEUTICAL REPORTS A LOSS ON ACQUISITION
TEVA PHARMACEUTICAL REPORTS A LOSS ON ACQUISITION
Teva Pharmaceutical Industries Ltd, pharmaceutical company, reversed to a Q1 loss of $1.40 per ADR, down from a profit of 38 cents per ADR a year-ago. On an adjusted basis, before one-time charges, it earned 37 cents per ADR.
123Jump.com (http://www.123jump.com/Earning-News-Headlines/Teva-Pharmaceutical-Reports-a-Loss-on-Acquisition/3157)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May